Louise Nicolin

Louise Nicolin discloses dealings in Enzymatica AB (publ) to Finansinspektionen. We count 31 filings; the first trade dates from 18 January 2019 and the latest from 15 November 2024.

Both buying and selling appear: 17 purchases worth €94k, against 4 sales worth €0. No amount is published for 3 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2024 to date brings 10 purchases and no sales.

A typical purchase (the median) is worth €3,790. Of 17 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

On 17 November 2024 came the latest disclosure, an open-market purchase for €3,377 in Enzymatica AB (publ). The median gap between a trade and its publication by Finansinspektionen is 3 days. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.